Rylaze
RxNorm concept 2561252, brand name (bn).
- RxCUI
- 2561252
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2561252 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- asparaginase Erwinia chrysanthemi (recombinant)-rywn (PIN, has precise ingredient)
- asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML [Rylaze] (SBDC, ingredient of)
- asparaginase Injection [Rylaze] (SBDF, ingredient of)
- Rylaze Injectable Product (SBDG, ingredient of)
- 0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze] (SBD, ingredient of)
- asparaginase (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2561252 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2561252 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2561252. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.